OJCD  Vol.8 No.3 , September 2018
Association between Urinary Neurotransmitter Status and Scoliosis Progression: A Case-Controlled Series
Abstract: Previous investigations into the relationship between neurotransmitter abnormalities and idiopathic scoliosis have been mixed. The purpose of the present study was to evaluate the differences in a urinary neurotransmitter profile across three different groups. These groups included a progressive scoliosis group, a non-progressive scoliosis group, and a non-scoliotic control group. When evaluating urinary neurotransmitter levels across all groups, statistically significant differences were observed between all three groups for multiple neurotransmitters. The differences seemed to increase as the scoliosis increased in Cobb angle measurement. Further studies should seek to distinguish a potential cause or effect relationship between these neurotransmitter abnormalities and idiopathic scoliosis onset and/or progression.
Cite this paper: Morningstar, M. , Stitzel, C. , Dovorany, B. and Siddiqui, A. (2018) Association between Urinary Neurotransmitter Status and Scoliosis Progression: A Case-Controlled Series. Open Journal of Clinical Diagnostics, 8, 17-24. doi: 10.4236/ojcd.2018.83003.

[1]   Machida, M., Dubousset, J., Imamura, Y., Iwaya, T., Yamada, T. and Kimura, J. (1995) Role of Melatonin Deficiency in the Development of Scoliosis in Pinealectomised Chickens. The Bone and Joint Journal, 77, 134-138.

[2]   Burwell, R.G., Aujla, R.K., Grevitt, M.P., Dangerfield, P.H., Moulton, A., Randell, T.L., et al. (2009) Pathogenesis of Adolescent Idiopathic Scoliosis in Girls—A Double Neuro-Osseous Theory Involving Disharmony between Two Nervous Systems, Somatic and Autonomic Expressed in the Spine and Trunk: Possible Dependency on Sympathetic Nervous System and Hormones with Implications for Medical Therapy. Scoliosis, 4, 24.

[3]   O’Kelly, C., Wang, X., Raso, J., Moreau, M., Mahood, J., Zhao, J., et al. (1999) The Production of Scoliosis after Pinealectomy in Young Chickens, Rats, and Hamsters. Spine, 24, 35-43.

[4]   Hillibrand, A.S., Blakemore, L.C., Loder, R.T., Greenfield, M.L., Farley, F.A., Hensinger, R.N., et al. (1996) The Role of Melatonin in the Pathogenesis of Adolescent Idiopathic Scoliosis. Spine, 21, 1140-1146.

[5]   Bagnall, K.M., Raso, V.J., Hill, D.L., Moreau, M., Mahood, J.K., Jiang, H., et al. (1996) Melatonin Levels in Idiopathic Scoliosis. Diurnal and Nocturnal Serum Melatonin Levels in Girls with Adolescent Idiopathic Scoliosis. Spine, 21, 1974-1978.

[6]   Fagan, A.B., Kennaway, D.J. and Sutherland, A.D. (1998) Total 24-Hour Melatonin Secretion in Adolescent Idiopathic Scoliosis. A Case-Control Study. Spine, 23, 41-46.

[7]   Moreau, A., Wang, D.S., Forget, S., Azeddine, B., Angeloni, D., Fraschini, F., Labelle, H., et al. (2004) Melatonin Signaling Dysfunction in Adolescent Idiopathic Scoliosis. Spine, 29, 1772-1781.

[8]   Wu, L., Qiu, Y., Wang, B., Yu, Y. and Zhu, Z. (2006) Asymmetric Expression of Melatonin Receptor mRNA in Bilateral Paravertebral Muscles in Adolescent Idiopathic Scoliosis. Studies in Health Technology and Informatics, 123, 129-134.

[9]   Azeddine, B., Letellier, K., Wang, D.S., Moldovan, F. and Moreau, A. (2007) Molecular Determinants of Melatonin Signaling Dysfunction in Adolescent Idiopathic Scoliosis. Clinical Orthopaedics and Related Research, 462, 45-52.

[10]   Qiu, Y., Wu, L., Wang, B., Yu, Y. and Zhu, Z. (2007) Asymmetric Expression of Melatonin Receptor mRNA in Bilateral Paravertebral Muscles in Adolescent Idiopathic Scoliosis. Spine, 32, 667-672.

[11]   Machida, M., Miyashita, Y., Murai, I., Dubousset, J., Yamada, T. and Kimura, J. (1997) Role of Serotonin for Scoliotic Deformity in Pinealectomized Chicken. Spine, 22, 1297-1301.

[12]   Gonzalez, R., Chávez-Pascacio, K. and Meneses, A. (2013) Role of 5-HT5A Receptors in the Consolidation of Memory. Behavioural Brain Research, 252, 246-251.

[13]   Frazer, A. and Hensler, J.G. (1999) Serotonin Involvement in Physiological Function and Behavior. In: Siegel, G.J., Agranoff, B.W., Albers, R.W., et al., Eds., Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th Edition, Lippincott-Raven, Philadelphia.

[14]   Modder, U.I., Achenbach, S.J., Amin, S., Riggs, B.L., Melton, L.J. and Khosla, S. (2010) Relation of Serum Serotonin Levels to Bone Density and Structural Parameters in Women. Journal of Bone and Mineral Research, 25, 415-422.

[15]   Israelyan, N. and Margolis, K.G. (2018) Serotonin as a Link between the Gut-Brain-Microbiome Axis in Autism Spectrum Disorders. Pharmacological Research, 132, 1-6.

[16]   Panula, P., Sundvik, M. and Karlstedt, K. (2014) Developmental Roles of Brain Histamine. Trends in Neurosciences, 37, 159-168.

[17]   Haas, H.L., Sergeeva, O.A. and Selbach, O. (2008) Histamine in the Nervous System. Physiological Reviews, 88, 1183-1241.

[18]   Zhou, Y. and Danbolt, N.C. (2014) Glutamate as a Neurotransmitter in the Healthy Brain. Journal of Neural Transmission, 121, 799-817.

[19]   Fernández-Montoya, J., Avendano, C. and Negredo, P. (2018) The Glutamatergic System in Primary Somatosensory Neurons and Its Involvement in Sensory Input-Dependent Plasticity. International Journal of Molecular Sciences, 19, 69.

[20]   Kania, B.F., Wrońska, D. and Zieba, D. (2017) Central Glutamatergic-Purinergic System Importance in Brain/Neural Plasticity. Journal of Behavioral and Brain Science, 7, 259-272.

[21]   Martins, A.R. and Froemke, R.C. (2015) Coordinated Forms of Noradrenergic Plasticity in the Locus Coeruleus and Primary Auditory Cortex. Nature Neuroscience, 18, 1483-1492.

[22]   Glennon, E., Carcea, I., Martins, A.R.O., Multani, J., Shehu, I., Svirsky, M.A. and Froemke, R.C. (2018) Locus Coeruleus Activation Accelerates Perceptual Learning. Brain Research.

[23]   Berridge, C.W. and Waterhouse, B.D. (2003) The Locus Coeruleus-Noradrenergic System: Modulation of Behavioral State and State-Dependent Cognitive Processes. Brain Research Reviews, 42, 33-84.

[24]   Morningstar, M. (2013) Neurotransmitter Patterns in Patients with Adolescent Idiopathic Scoliosis (AIS). Scoliosis, 8, O1.

[25]   Morningstar, M.W., Siddiqui, A., Dovorany, B. and Stitzel, C.J. (2014) Can Neurotransmitter Status Affect the Results of Exercise-Based Scoliosis Treatment? Results of a Controlled Comparative Chart Review. Alternative and Integrative Medicine, 3, 177.

[26]   Morningstar, M.W., Pettibon, B.R., Schlappi, H., Schlappi, M. and Ireland, T.V. (2005) Reflex Control of the Spine and Posture: A Review of the Literature from a Chiropractic Perspective. Chiropractic & Osteopathy, 13, 16.

[27]   Hinz, M., Stein, A., Trachte, G. and Uncini, T. (2010) Neurotransmitter Testing of the Urine: A Comprehensive Analysis. Open Access Journal of Urology, 2, 177-183.

[28]   Reuben, D.B., Talvi, S.L.A., Rowe, J.W. and Seeman, T.E. (2000) High Urinary Catecholamine Excretion Predicts Mortality and Functional Decline in High-Functioning, Community-Dwelling Older Persons: MacArthur Studies of Successful Aging. Journal of Gerontology: Medical Sciences, 55A, M618-M624.

[29]   Dvorakova, M., Jezova, D., Blazicek, P., Trebaticka, J., Skodacek, I., Suba, J., et al. (2007) Urinary Catecholamines in Children with Attention Deficit Hyperactivity Disorder (ADHD): Modulation by a Polyphenolic Extract from Pine Bark (Pycnogenol). Nutritional Neuroscience, 10, 151-157.